These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31869496)

  • 1. Annexin A6 improves anti-migratory and anti-invasive properties of tyrosine kinase inhibitors in EGFR overexpressing human squamous epithelial cells.
    Hoque M; Elmaghrabi YA; Köse M; Beevi SS; Jose J; Meneses-Salas E; Blanco-Muñoz P; Conway JRW; Swarbrick A; Timpson P; Tebar F; Enrich C; Rentero C; Grewal T
    FEBS J; 2020 Jul; 287(14):2961-2978. PubMed ID: 31869496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.
    Koese M; Rentero C; Kota BP; Hoque M; Cairns R; Wood P; Vilà de Muga S; Reverter M; Alvarez-Guaita A; Monastyrskaya K; Hughes WE; Swarbrick A; Tebar F; Daly RJ; Enrich C; Grewal T
    Oncogene; 2013 Jun; 32(23):2858-72. PubMed ID: 22797061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation of AnxA6 facilitates EGFR-PKCα complex formation to suppress epithelial cancer growth.
    Sheng Z; Cao X; Deng YN; Zhao X; Liang S
    Cell Commun Signal; 2023 Aug; 21(1):189. PubMed ID: 37528485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors.
    Koumangoye RB; Nangami GN; Thompson PD; Agboto VK; Ochieng J; Sakwe AM
    Mol Cancer; 2013 Dec; 12(1):167. PubMed ID: 24354805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A6 inhibits Ras signalling in breast cancer cells.
    Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
    Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors.
    Widatalla SE; Korolkova OY; Whalen DS; Goodwin JS; Williams KP; Ochieng J; Sakwe AM
    Carcinogenesis; 2019 Aug; 40(8):998-1009. PubMed ID: 30590459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A6-A multifunctional scaffold in cell motility.
    Grewal T; Hoque M; Conway JRW; Reverter M; Wahba M; Beevi SS; Timpson P; Enrich C; Rentero C
    Cell Adh Migr; 2017 May; 11(3):288-304. PubMed ID: 28060548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular modulation of signaling pathways by annexin A6 regulates terminal differentiation of chondrocytes.
    Minashima T; Small W; Moss SE; Kirsch T
    J Biol Chem; 2012 Apr; 287(18):14803-15. PubMed ID: 22399299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
    Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
    Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.
    Guix M; Faber AC; Wang SE; Olivares MG; Song Y; Qu S; Rinehart C; Seidel B; Yee D; Arteaga CL; Engelman JA
    J Clin Invest; 2008 Jul; 118(7):2609-19. PubMed ID: 18568074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity.
    Grewal T; Evans R; Rentero C; Tebar F; Cubells L; de Diego I; Kirchhoff MF; Hughes WE; Heeren J; Rye KA; Rinninger F; Daly RJ; Pol A; Enrich C
    Oncogene; 2005 Sep; 24(38):5809-20. PubMed ID: 15940262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration.
    García-Melero A; Reverter M; Hoque M; Meneses-Salas E; Koese M; Conway JR; Johnsen CH; Alvarez-Guaita A; Morales-Paytuvi F; Elmaghrabi YA; Pol A; Tebar F; Murray RZ; Timpson P; Enrich C; Grewal T; Rentero C
    J Biol Chem; 2016 Jan; 291(3):1320-35. PubMed ID: 26578516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
    Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
    Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A6 and NPC1 regulate LDL-inducible cell migration and distribution of focal adhesions.
    Jose J; Hoque M; Engel J; Beevi SS; Wahba M; Georgieva MI; Murphy KJ; Hughes WE; Cochran BJ; Lu A; Tebar F; Hoy AJ; Timpson P; Rye KA; Enrich C; Rentero C; Grewal T
    Sci Rep; 2022 Jan; 12(1):596. PubMed ID: 35022465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model.
    Gong J; Yang DJ; Kohanim S; Angelo LS; Kurzrock R
    Cancer Biol Ther; 2009 Dec; 8(23):2239-47. PubMed ID: 19823028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
    Yoshida J; Ishibashi T; Yang M; Nishio M
    Life Sci; 2010 Jan; 86(3-4):124-32. PubMed ID: 19951711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.
    Sakwe AM; Koumangoye R; Guillory B; Ochieng J
    Exp Cell Res; 2011 Apr; 317(6):823-37. PubMed ID: 21185831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists.
    Williams SD; Smith TM; Stewart LV; Sakwe AM
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.